サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1559008

尿道カテーテル市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年

Urinary Catheters Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 212 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
尿道カテーテル市場：世界の産業分析、規模、シェア、成長、動向、予測、2024-2033年
出版日: 2024年09月13日
発行: Persistence Market Research
ページ情報: 英文 212 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、世界の尿道カテーテル市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因、動向、機会、課題など、重要な市場ダイナミクスを詳細に分析し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 尿道カテーテルの市場規模（2024E）：20億米ドル
  • 市場予測数量（2033F）：32億米ドル
  • 世界市場成長率（CAGR 2024年から2033年まで）：5.3%

尿道カテーテル市場：調査範囲

尿道カテーテルは、患者が自然に排尿できない場合に膀胱から尿を排出するために使用される必須の医療機器です。これらの器具は、尿失禁、尿閉、手術後の回復など、さまざまな泌尿器科疾患の管理において重要な役割を果たしています。尿道カテーテル市場は、病院、長期介護施設、在宅介護環境、診療所などを対象としており、間欠カテーテル、留置カテーテル、体外カテーテルなど、さまざまなタイプのカテーテルを提供しています。市場成長の原動力は、泌尿器疾患の有病率の増加、高齢者人口の増加、カテーテル技術の進歩による患者の快適性の向上と感染率の低下などの要因です。

市場促進要因：

世界の尿道カテーテル市場は、尿失禁やその他の泌尿器疾患の有病率の上昇など、いくつかの主要な要因によって牽引されています。排尿問題を経験しやすい高齢者人口の増加が市場拡大に大きく寄与しています。抗菌コーティングや親水性コーティングの開発など、カテーテル設計の技術的進歩は患者の安全性と快適性を高める。また、在宅医療や外来診療の導入が増加していることから、患者はより便利で快適なケアの選択肢を求めるようになり、市場成長の新たな機会が生まれています。

市場抑制要因：

有望な成長見通しにもかかわらず、尿道カテーテル市場は感染リスク、規制上のハードル、コスト制約に関する課題に直面しています。カテーテル関連尿路感染症（CAUTI）のリスクは依然として大きな懸念事項であり、ヘルスケアコストの増加と患者の転帰への影響につながります。厳しい規制要件と安全基準遵守の必要性は、メーカーにとって課題となっています。さらに、先進的なカテーテル技術のコストが高いことや、地域によっては償還範囲が限られていることが、特に低所得国や新興経済国での市場浸透の妨げとなっています。

市場機会：

尿道カテーテル市場は、技術革新、人口動向、ヘルスケア提供モデルの進化によって大きな成長機会がもたらされます。センサーや遠隔医療機能を統合したスマートカテーテルを含む先進的なカテーテル技術の開発により、患者のモニタリングと管理が改善されます。革新的なカテーテル設計と感染予防戦略を通じてCAUTIを最小限に抑えることにますます注目が集まっているため、市場関係者には成長の道が開けています。戦略的パートナーシップ、研究開発への投資、新興国市場への進出は、こうした機会を活用し市場成長を促進するために不可欠です。

本レポートで扱う主な質問

  • 尿道カテーテル市場の世界的成長を促進する主な要因は何か？
  • さまざまなヘルスケア環境で尿道カテーテルの採用を促進しているカテーテルの種類と用途は何か？
  • 技術の進歩は尿道カテーテル市場の競合情勢をどのように変えているのか？
  • 尿道カテーテル市場に貢献している主要プレイヤーは誰で、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界の尿道カテーテル市場における新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 市場イノベーション/開発動向

第4章 重要成功要因

  • 製品採用分析
  • 規制状況
  • 払い戻しシナリオ
  • サプライチェーン分析
  • ポーターの分析
  • PESTLE分析
  • 技術評価

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • COVID-19と影響分析
    • 製品別
    • アプリケーション別
    • 地域別
  • 2023年の市場シナリオ

第7章 世界市場数量分析

  • 市場数量分析、2019～2023年
  • 市場数量予測、2024～2033年
    • 前年比成長動向分析

第8章 世界市場- 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク
  • 価格設定の前提

第9章 世界市場需要（金額）分析

  • 市場金額分析、2019～2023年
  • 市場規模予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 製品別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 間欠カテーテル
    • 留置カテーテル
    • 外部カテーテル
  • 製品別市場の魅力分析

第11章 アプリケーション別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額）分析、2019～2023年
  • 市場規模（金額）分析と予測、2024～2033年
    • 尿失禁
    • 尿閉
    • 前立腺手術
    • 脊髄損傷
    • その他
  • アプリケーション別市場の魅力分析

第12章 地域別：世界市場分析

  • イントロダクション/主な調査結果
  • 市場規模（金額および数量）分析、2019～2023年
  • 市場規模（金額および数量）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 地域別市場の魅力分析

第13章 北米市場分析

第14章 ラテンアメリカ市場分析

第15章 欧州市場分析

第16章 東アジア市場分析

第17章 南アジア市場分析

第18章 オセアニア市場

第19章 中東・アフリカ（中東・アフリカ）市場分析

第20章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第21章 競合分析

  • 競合ダッシュボード
  • 主要プレーヤーによるブランディングとプロモーション戦略
  • 主要開発分析
  • 競合の詳細
    • B. Braun Melsungen AG
    • Coloplast A/S
    • Becton, Dickinson and Company
    • Teleflex Incorporation
    • Boston Scientific Corporation
    • Medtronic plc.
    • Hollister Incorporate
    • Cook Medical
    • Cathetrix
    • UroDev Medical
    • Stryker Corporation
    • Consure Medical
    • J and M Urinary Catherters LLC
    • Urocare Products Inc.
    • Wellspect Healthcare
    • CompactCath
    • ConvaTec
    • Cardinal Health, Inc.
    • Amsino International Inc.

第22章 使用される前提条件と頭字語

第23章 調査手法

目次
Product Code: PMRREP3268

Persistence Market Research has recently released a comprehensive report on the global urinary catheters market. The report provides an in-depth analysis of critical market dynamics, including drivers, trends, opportunities, and challenges, delivering detailed insights into the market structure.

Key Insights:

  • Urinary Catheters Market Size (2024E): US$ 2.0 Billion
  • Projected Market Value (2033F): US$ 3.2 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 5.3%

Urinary Catheters Market - Report Scope:

Urinary catheters are essential medical devices used to drain urine from the bladder when patients are unable to urinate naturally. These devices play a crucial role in the management of various urological conditions, including urinary incontinence, urinary retention, and post-surgical recovery. The urinary catheters market serves hospitals, long-term care facilities, home care settings, and clinics, offering a range of catheter types, including intermittent, indwelling, and external catheters. Market growth is driven by factors such as increasing prevalence of urological disorders, rising geriatric population, and advancements in catheter technology, improving patient comfort and reducing infection rates.

Market Growth Drivers:

The global urinary catheters market is driven by several key factors, including the rising prevalence of urinary incontinence and other urological conditions. The growing elderly population, who are more likely to experience urinary issues, is contributing significantly to market expansion. Technological advancements in catheter design, such as the development of antimicrobial coatings and hydrophilic coatings, enhance patient safety and comfort. Additionally, the increasing adoption of homecare settings and outpatient services creates new opportunities for market growth as patients seek more convenient and comfortable care options.

Market Restraints:

Despite promising growth prospects, the urinary catheters market faces challenges related to infection risks, regulatory hurdles, and cost constraints. The risk of catheter-associated urinary tract infections (CAUTIs) remains a significant concern, leading to increased healthcare costs and impacting patient outcomes. Stringent regulatory requirements and the need for compliance with safety standards pose challenges for manufacturers. Additionally, the high cost of advanced catheter technologies and limited reimbursement coverage in some regions can hinder market penetration, particularly in low-income and emerging economies.

Market Opportunities:

The urinary catheters market presents substantial growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of advanced catheter technologies, including smart catheters with integrated sensors and telehealth capabilities, offers improved patient monitoring and management. The increasing focus on minimizing CAUTIs through innovative catheter designs and infection prevention strategies creates growth avenues for market players. Strategic partnerships, investment in research and development, and expansion into emerging markets are essential to capitalize on these opportunities and drive market growth.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the urinary catheters market globally?
  • Which catheter types and applications are driving urinary catheter adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the urinary catheters market?
  • Who are the key players contributing to the urinary catheters market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global urinary catheters market?

Competitive Intelligence and Business Strategy:

Leading players in the global urinary catheters market, including Boston Scientific Corporation, Coloplast Corp., and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced catheter solutions, including those with antimicrobial and hydrophilic coatings, catering to diverse patient needs and clinical requirements. Collaborations with healthcare providers, distributors, and regulatory agencies facilitate market access and promote technology adoption. Emphasis on patient safety, clinical research, and education further enhances market growth and improves patient outcomes in the rapidly evolving urinary catheters landscape.

Key Companies Profiled:

  • Boston Scientific Corporation
  • Coloplast Corp.
  • Medtronic plc
  • B. Braun Melsungen AG
  • ConvaTec Group PLC
  • Hollister Incorporated
  • Teleflex Incorporated
  • Smiths Medical
  • Cook Medical
  • C.R. Bard, Inc.

Key Segments Covered in Urinary Catheters Market Research

By Product

  • Intermittent Catheter
  • Indwelling (Foley) Catheter
  • External Catheter

By Application

  • Urinary Incontinence
  • Urinary Retention
  • Prostate Gland Surgery
  • Spinal Cord Injury

By Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Market Innovation / Development Trends

4. Key Success Factors

  • 4.1. Product Adoption Analysis
  • 4.2. Regulatory Landscape
  • 4.3. Reimbursement Scenario
  • 4.4. Supply Chain Analysis
  • 4.5. Porter's Analysis
  • 4.6. PESTLE Analysis
  • 4.7. Technological Assessment

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP outlook
    • 5.1.2. Global Healthcare Expenditure Outlook
    • 5.1.3. Global Urology Device Market Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Growing Healthcare Expenditure
    • 5.2.2. Adoption of Urinary Catheters
    • 5.2.3. Rising Incidence of Lower Urinary Tract Problems
    • 5.2.4. Increase in the Number of Prostate Cancer
    • 5.2.5. New Product Launches
    • 5.2.6. Investment in Research and Development to offer better products
    • 5.2.7. Cost of Product
    • 5.2.8. Strategic Collaboration Among Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. COVID-19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Application
    • 6.1.3. By Region
  • 6.2. 2023 Market Scenario

7. Global Market Volume (000 Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (000 Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (000 Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Product
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark
  • 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Size (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (000 Units) Analysis by Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Product, 2024-2033
    • 10.3.1. Intermittent Catheter
    • 10.3.2. Indwelling (Foley) Catheter
    • 10.3.3. External Catheter
  • 10.4. Market Attractiveness Analysis by Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Application, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Application, 2024-2033
    • 11.3.1. Urinary Incontinence
    • 11.3.2. Urinary Retention
    • 11.3.3. Prostate Gland Surgery
    • 11.3.4. Spinal Cord Injury
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis by Application

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) and Volume (000 Units) Analysis, by Region, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Region, 2024-2033
    • 12.3.1. North America
    • 12.3.2. Latin America
    • 12.3.3. Europe
    • 12.3.4. East Asia
    • 12.3.5. South Asia
    • 12.3.6. Oceania
    • 12.3.7. Middle East & Africa
  • 12.4. Market Attractiveness Analysis by Region

13. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 13.3.1. By Country
      • 13.3.1.1. U.S.
      • 13.3.1.2. Canada
    • 13.3.2. By Product
    • 13.3.3. By Application
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Country
    • 13.4.2. By Product
    • 13.4.3. By Application
  • 13.5. Market Trends
  • 13.6. Key Market Participants - Intensity Mapping
  • 13.7. Drivers and Restraints - Impact Analysis
  • 13.8. Country Level Analysis & Forecast
    • 13.8.1. U.S. Market
      • 13.8.1.1. Introduction
      • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.1.2.1. By Product
        • 13.8.1.2.2. By Application
    • 13.8.2. Canada Market
      • 13.8.2.1. Introduction
      • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 13.8.2.2.1. By Product
        • 13.8.2.2.2. By Application

14. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. Mexico
      • 14.3.1.2. Brazil
      • 14.3.1.3. Argentina
      • 14.3.1.4. Rest of Latin America
    • 14.3.2. By Product
    • 14.3.3. By Application
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Application
  • 14.5. Market Trends
  • 14.6. Key Market Participants - Intensity Mapping
  • 14.7. Drivers and Restraints - Impact Analysis
  • 14.8. Country Level Analysis & Forecast
    • 14.8.1. Mexico Market Analysis
      • 14.8.1.1. Introduction
      • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.1.2.1. By Product
        • 14.8.1.2.2. By Application
    • 14.8.2. Brazil Market Analysis
      • 14.8.2.1. Introduction
      • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.2.2.1. By Product
        • 14.8.2.2.2. By Application
    • 14.8.3. Argentina Market Analysis
      • 14.8.3.1. Introduction
      • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 14.8.3.2.1. By Product
        • 14.8.3.2.2. By Application

15. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Germany
      • 15.3.1.2. Italy
      • 15.3.1.3. France
      • 15.3.1.4. U.K.
      • 15.3.1.5. Spain
      • 15.3.1.6. BENELUX
      • 15.3.1.7. Russia
      • 15.3.1.8. Rest of Europe
    • 15.3.2. By Product
    • 15.3.3. By Application
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Application
  • 15.5. Market Trends
  • 15.6. Key Market Participants - Intensity Mapping
  • 15.7. Drivers and Restraints - Impact Analysis
  • 15.8. Country Level Analysis & Forecast
    • 15.8.1. Germany Market Analysis
      • 15.8.1.1. Introduction
      • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.1.2.1. By Product
        • 15.8.1.2.2. By Application
    • 15.8.2. Italy Market Analysis
      • 15.8.2.1. Introduction
      • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.2.2.1. By Product
        • 15.8.2.2.2. By Application
    • 15.8.3. France Market Analysis
      • 15.8.3.1. Introduction
      • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.3.2.1. By Product
        • 15.8.3.2.2. By Application
    • 15.8.4. U.K. Market Analysis
      • 15.8.4.1. Introduction
      • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.4.2.1. By Product
        • 15.8.4.2.2. By Application
    • 15.8.5. Spain Market Analysis
      • 15.8.5.1. Introduction
      • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.5.2.1. By Product
        • 15.8.5.2.2. By Application
    • 15.8.6. BENELUX Market Analysis
      • 15.8.6.1. Introduction
      • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.6.2.1. By Product
        • 15.8.6.2.2. By Application
    • 15.8.7. Russia Market Analysis
      • 15.8.7.1. Introduction
      • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
        • 15.8.7.2.1. By Product
        • 15.8.7.2.2. By Application

16. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. China
      • 16.3.1.2. Japan
      • 16.3.1.3. South Korea
    • 16.3.2. By Product
    • 16.3.3. By Application
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Application
  • 16.5. Market Trends
  • 16.6. Key Market Participants - Intensity Mapping
  • 16.7. Drivers and Restraints - Impact Analysis
  • 16.8. Country Level Analysis & Forecast
    • 16.8.1. China Market Analysis
      • 16.8.1.1. Introduction
      • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.1.2.1. By Product
        • 16.8.1.2.2. By Application
    • 16.8.2. Japan Market Analysis
      • 16.8.2.1. Introduction
      • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.2.2.1. By Product
        • 16.8.2.2.2. By Application
    • 16.8.3. South Korea Market Analysis
      • 16.8.3.1. Introduction
      • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.8.3.2.1. By Product
        • 16.8.3.2.2. By Application

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Indonesia
      • 17.3.1.3. Malaysia
      • 17.3.1.4. Thailand
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Product
    • 17.3.3. By Application
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Application
  • 17.5. Market Trends
  • 17.6. Key Market Participants - Intensity Mapping
  • 17.7. Drivers and Restraints - Impact Analysis
  • 17.8. Country Level Analysis & Forecast
    • 17.8.1. India Market Analysis
      • 17.8.1.1. Introduction
      • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.1.2.1. By Product
        • 17.8.1.2.2. By Application
    • 17.8.2. Indonesia Market Analysis
      • 17.8.2.1. Introduction
      • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.2.2.1. By Product
        • 17.8.2.2.2. By Application
    • 17.8.3. Malaysia Market Analysis
      • 17.8.3.1. Introduction
      • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.3.2.1. By Product
        • 17.8.3.2.2. By Application
    • 17.8.4. Thailand Market Analysis
      • 17.8.4.1. Introduction
      • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.8.4.2.1. By Product
        • 17.8.4.2.2. By Application

18. Oceania Market 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. Australia
      • 18.3.1.2. New Zealand
    • 18.3.2. By Product
    • 18.3.3. By Application
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Application
  • 18.5. Market Trends
  • 18.6. Key Market Participants - Intensity Mapping
  • 18.7. Drivers and Restraints - Impact Analysis
  • 18.8. Country Level Analysis & Forecast
    • 18.8.1. Australia Market Analysis
      • 18.8.1.1. Introduction
      • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.1.2.1. By Product
        • 18.8.1.2.2. By Application
    • 18.8.2. New Zealand Market Analysis
      • 18.8.2.1. Introduction
      • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.8.2.2.1. By Product
        • 18.8.2.2.2. By Application

19. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (000 Units) Trend Analysis by Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Size (US$ Bn) and Volume (000 Units) Analysis and Forecast by Market Taxonomy, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. GCC Countries
      • 19.3.1.2. Turkiye
      • 19.3.1.3. North Africa
      • 19.3.1.4. South Africa
      • 19.3.1.5. Rest of Middle East and Africa
    • 19.3.2. By Product
    • 19.3.3. By Application
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Application
  • 19.5. Market Trends
  • 19.6. Key Market Participants - Intensity Mapping
  • 19.7. Drivers and Restraints - Impact Analysis
  • 19.8. Country Level Analysis & Forecast
    • 19.8.1. GCC Countries Market Analysis
      • 19.8.1.1. Introduction
      • 19.8.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.1.2.1. By Product
        • 19.8.1.2.2. By Application
    • 19.8.2. Turkiye Market Analysis
      • 19.8.2.1. Introduction
      • 19.8.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.2.2.1. By Product
        • 19.8.2.2.2. By Application
    • 19.8.3. South Africa Market Analysis
      • 19.8.3.1. Introduction
      • 19.8.3.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.3.2.1. By Product
        • 19.8.3.2.2. By Application
    • 19.8.4. North Africa Market Analysis
      • 19.8.4.1. Introduction
      • 19.8.4.2. Market Analysis and Forecast by Market Taxonomy
        • 19.8.4.2.1. By Product
        • 19.8.4.2.2. By Application

20. Market Structure Analysis

  • 20.1. Market Analysis by Tier of Companies
  • 20.2. Market Share Analysis of Top Players
  • 20.3. Market Presence Analysis

21. Competition Analysis

  • 21.1. Competition Dashboard
  • 21.2. Branding and Promotional Strategies, By Key Players
  • 21.3. Key Development Analysis
  • 21.4. Competition Deep Dive
    • 21.4.1. B. Braun Melsungen AG
      • 21.4.1.1. Overview
      • 21.4.1.2. Product Portfolio
      • 21.4.1.3. Sales Footprint
      • 21.4.1.4. Key Financials
      • 21.4.1.5. SWOT Analysis
      • 21.4.1.6. Key Developments
      • 21.4.1.7. Strategy Overview
        • 21.4.1.7.1. Marketing Strategy
        • 21.4.1.7.2. Product Strategy
        • 21.4.1.7.3. Channel Strategy
    • 21.4.2. Coloplast A/S
      • 21.4.2.1. Overview
      • 21.4.2.2. Product Portfolio
      • 21.4.2.3. Sales Footprint
      • 21.4.2.4. Key Financials
      • 21.4.2.5. SWOT Analysis
      • 21.4.2.6. Key Developments
      • 21.4.2.7. Strategy Overview
        • 21.4.2.7.1. Marketing Strategy
        • 21.4.2.7.2. Product Strategy
        • 21.4.2.7.3. Channel Strategy
    • 21.4.3. Becton, Dickinson and Company
      • 21.4.3.1. Overview
      • 21.4.3.2. Product Portfolio
      • 21.4.3.3. Sales Footprint
      • 21.4.3.4. Key Financials
      • 21.4.3.5. SWOT Analysis
      • 21.4.3.6. Key Developments
      • 21.4.3.7. Strategy Overview
        • 21.4.3.7.1. Marketing Strategy
        • 21.4.3.7.2. Product Strategy
        • 21.4.3.7.3. Channel Strategy
    • 21.4.4. Teleflex Incorporation
      • 21.4.4.1. Overview
      • 21.4.4.2. Product Portfolio
      • 21.4.4.3. Sales Footprint
      • 21.4.4.4. Key Financials
      • 21.4.4.5. SWOT Analysis
      • 21.4.4.6. Key Developments
      • 21.4.4.7. Strategy Overview
        • 21.4.4.7.1. Marketing Strategy
        • 21.4.4.7.2. Product Strategy
        • 21.4.4.7.3. Channel Strategy
    • 21.4.5. Boston Scientific Corporation
      • 21.4.5.1. Overview
      • 21.4.5.2. Product Portfolio
      • 21.4.5.3. Sales Footprint
      • 21.4.5.4. Key Financials
      • 21.4.5.5. SWOT Analysis
      • 21.4.5.6. Key Developments
      • 21.4.5.7. Strategy Overview
        • 21.4.5.7.1. Marketing Strategy
        • 21.4.5.7.2. Product Strategy
        • 21.4.5.7.3. Channel Strategy
    • 21.4.6. Medtronic plc.
      • 21.4.6.1. Overview
      • 21.4.6.2. Product Portfolio
      • 21.4.6.3. Sales Footprint
      • 21.4.6.4. Key Financials
      • 21.4.6.5. SWOT Analysis
      • 21.4.6.6. Key Developments
      • 21.4.6.7. Strategy Overview
        • 21.4.6.7.1. Marketing Strategy
        • 21.4.6.7.2. Product Strategy
        • 21.4.6.7.3. Channel Strategy
    • 21.4.7. Hollister Incorporate
      • 21.4.7.1. Overview
      • 21.4.7.2. Product Portfolio
      • 21.4.7.3. Sales Footprint
      • 21.4.7.4. Key Financials
      • 21.4.7.5. SWOT Analysis
      • 21.4.7.6. Key Developments
      • 21.4.7.7. Strategy Overview
        • 21.4.7.7.1. Marketing Strategy
        • 21.4.7.7.2. Product Strategy
        • 21.4.7.7.3. Channel Strategy
    • 21.4.8. Cook Medical
      • 21.4.8.1. Overview
      • 21.4.8.2. Product Portfolio
      • 21.4.8.3. Sales Footprint
      • 21.4.8.4. Key Financials
      • 21.4.8.5. SWOT Analysis
      • 21.4.8.6. Key Developments
      • 21.4.8.7. Strategy Overview
        • 21.4.8.7.1. Marketing Strategy
        • 21.4.8.7.2. Product Strategy
        • 21.4.8.7.3. Channel Strategy
    • 21.4.9. Cathetrix
      • 21.4.9.1. Overview
      • 21.4.9.2. Product Portfolio
      • 21.4.9.3. Sales Footprint
      • 21.4.9.4. Key Financials
      • 21.4.9.5. SWOT Analysis
      • 21.4.9.6. Key Developments
      • 21.4.9.7. Strategy Overview
        • 21.4.9.7.1. Marketing Strategy
        • 21.4.9.7.2. Product Strategy
        • 21.4.9.7.3. Channel Strategy
    • 21.4.10. UroDev Medical
      • 21.4.10.1. Overview
      • 21.4.10.2. Product Portfolio
      • 21.4.10.3. Sales Footprint
      • 21.4.10.4. Key Financials
      • 21.4.10.5. SWOT Analysis
      • 21.4.10.6. Key Developments
      • 21.4.10.7. Strategy Overview
        • 21.4.10.7.1. Marketing Strategy
        • 21.4.10.7.2. Product Strategy
        • 21.4.10.7.3. Channel Strategy
    • 21.4.11. Stryker Corporation
      • 21.4.11.1. Overview
      • 21.4.11.2. Product Portfolio
      • 21.4.11.3. Sales Footprint
      • 21.4.11.4. Key Financials
      • 21.4.11.5. SWOT Analysis
      • 21.4.11.6. Key Developments
      • 21.4.11.7. Strategy Overview
        • 21.4.11.7.1. Marketing Strategy
        • 21.4.11.7.2. Product Strategy
        • 21.4.11.7.3. Channel Strategy
    • 21.4.12. Consure Medical
      • 21.4.12.1. Overview
      • 21.4.12.2. Product Portfolio
      • 21.4.12.3. Sales Footprint
      • 21.4.12.4. Key Financials
      • 21.4.12.5. SWOT Analysis
      • 21.4.12.6. Key Developments
      • 21.4.12.7. Strategy Overview
        • 21.4.12.7.1. Marketing Strategy
        • 21.4.12.7.2. Product Strategy
        • 21.4.12.7.3. Channel Strategy
    • 21.4.13. J and M Urinary Catherters LLC
      • 21.4.13.1. Overview
      • 21.4.13.2. Product Portfolio
      • 21.4.13.3. Sales Footprint
      • 21.4.13.4. Key Financials
      • 21.4.13.5. SWOT Analysis
      • 21.4.13.6. Key Developments
      • 21.4.13.7. Strategy Overview
        • 21.4.13.7.1. Marketing Strategy
        • 21.4.13.7.2. Product Strategy
        • 21.4.13.7.3. Channel Strategy
    • 21.4.14. Urocare Products Inc.
      • 21.4.14.1. Overview
      • 21.4.14.2. Product Portfolio
      • 21.4.14.3. Sales Footprint
      • 21.4.14.4. Key Financials
      • 21.4.14.5. SWOT Analysis
      • 21.4.14.6. Key Developments
      • 21.4.14.7. Strategy Overview
        • 21.4.14.7.1. Marketing Strategy
        • 21.4.14.7.2. Product Strategy
        • 21.4.14.7.3. Channel Strategy
    • 21.4.15. Wellspect Healthcare
      • 21.4.15.1. Overview
      • 21.4.15.2. Product Portfolio
      • 21.4.15.3. Sales Footprint
      • 21.4.15.4. Key Financials
      • 21.4.15.5. SWOT Analysis
      • 21.4.15.6. Key Developments
      • 21.4.15.7. Strategy Overview
        • 21.4.15.7.1. Marketing Strategy
        • 21.4.15.7.2. Product Strategy
        • 21.4.15.7.3. Channel Strategy
    • 21.4.16. CompactCath
      • 21.4.16.1. Overview
      • 21.4.16.2. Product Portfolio
      • 21.4.16.3. Sales Footprint
      • 21.4.16.4. Key Financials
      • 21.4.16.5. SWOT Analysis
      • 21.4.16.6. Key Developments
      • 21.4.16.7. Strategy Overview
        • 21.4.16.7.1. Marketing Strategy
        • 21.4.16.7.2. Product Strategy
        • 21.4.16.7.3. Channel Strategy
    • 21.4.17. ConvaTec
      • 21.4.17.1. Overview
      • 21.4.17.2. Product Portfolio
      • 21.4.17.3. Sales Footprint
      • 21.4.17.4. Key Financials
      • 21.4.17.5. SWOT Analysis
      • 21.4.17.6. Key Developments
      • 21.4.17.7. Strategy Overview
        • 21.4.17.7.1. Marketing Strategy
        • 21.4.17.7.2. Product Strategy
        • 21.4.17.7.3. Channel Strategy
    • 21.4.18. Cardinal Health, Inc.
      • 21.4.18.1. Overview
      • 21.4.18.2. Product Portfolio
      • 21.4.18.3. Sales Footprint
      • 21.4.18.4. Key Financials
      • 21.4.18.5. SWOT Analysis
      • 21.4.18.6. Key Developments
      • 21.4.18.7. Strategy Overview
        • 21.4.18.7.1. Marketing Strategy
        • 21.4.18.7.2. Product Strategy
        • 21.4.18.7.3. Channel Strategy
    • 21.4.19. Amsino International Inc.
      • 21.4.19.1. Overview
      • 21.4.19.2. Product Portfolio
      • 21.4.19.3. Sales Footprint
      • 21.4.19.4. Key Financials
      • 21.4.19.5. SWOT Analysis
      • 21.4.19.6. Key Developments
      • 21.4.19.7. Strategy Overview
        • 21.4.19.7.1. Marketing Strategy
        • 21.4.19.7.2. Product Strategy
        • 21.4.19.7.3. Channel Strategy

22. Assumptions and Acronyms Used

23. Research Methodology